EUVIMEDEUVIMED entdecken
Open Access

Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway

Yanbin Zhang, Tao Zhang, Long Chen, Zijun Guo, Xiaobing Jiang

Aging · 2024

DOI: 10.18632/aging.205972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Yanbin Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Osteosarcoma, TOR Serine-Threonine Kinases, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaTOR Serine-Threonine KinasesDrug Resistance, NeoplasmProto-Oncogene Proteins c-aktDoxorubicinPhosphatidylinositol 3-KinasesSignal TransductionBone NeoplasmsHumansCell Line, TumorCell ProliferationAntibiotics, AntineoplasticCell MovementDisease ProgressionMaleFemaleGene Expression Regulation, NeoplasticPrognosis

Stichwörter der Autor:innen

AdriamycinCCNL1PI3K/AKT-mTORchemoresistanceosteosarcomaprognosis

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktDoxorubicinPhosphatidylinositol 3-KinasesMTOR protein, humanAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Key Laboratory of Anesthesiology and Resuscitation, Huazhong University of Science and Technology, Ministry of Education, Wuhan 430022, China.
  • Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430062, China.

Zitieren

APA

Zhang, Y., Zhang, T., Chen, L., Guo, Z., & Jiang, X. (2024). Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway. Aging. https://doi.org/10.18632/aging.205972

Vancouver

Zhang Y, Zhang T, Chen L, Guo Z, Jiang X. Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway. Aging. 2024. doi:10.18632/aging.205972

BibTeX
@article{Zhang2024,
  author = {Zhang, Yanbin and Zhang, Tao and Chen, Long and Guo, Zijun and Jiang, Xiaobing},
  title = {Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205972}
}
Kostenlos starten →